Events - Spark Newswire

2 minute read

9 Meters Biopharma Presents Preclinical Data On Glucose-Dependent Insulinotropic Polypeptide Monoclonal Antibodies For Obesity At The American College Of Gastroenterology 2022 Annual Scientific Meeting October 21-26

Today, 8:12 PM

Preclinical data investigated the use of glucose-dependent insulinotropic polypeptide (GIP) monoclonal antibodies (mAbs) to prevent and treat obesity in animal models Poster granted Outstanding Research Award 9

NMTR

2 minute read

Verizon Vs. AT&T: How These High Yielders Stack Up On Dividends

By Robert Kuczmarski

Today, 8:12 PM

As we enter the third-quarter earnings season, many investors will be analyzing stocks for future trades.

AXP

2 minute read

Phathom Pharmaceuticals Presents New Data Evaluating First-in-Class Potassium-Competitive Acid Blocker (PCAB) Vonoprazan as Novel On-Demand Treatment in NERD at AGC Annual Scientific Meeting; Said Primary Endpoint Was Met for All Three Doses of Vonopra…

By Charles Gross

Today, 8:12 PM

Phathom Pharmaceuticals, Inc.

PHAT

2 minute read

Biden’s Plan To Help Taxpayers At The Gas Pump Comes As Strategic Reserves Fall To 1984 Levels

By Robert Kuczmarski

Today, 8:12 PM

President Joe Biden announced on Oct. 19 the release of 15 million barrels of oil from the strategic petroleum reserve (SPR) due to recent production cuts announced by the OPEC + coalition.

XOM

2 minute read

Sermonix Pharmaceuticals Shares Additional Findings From Its Evaluation Of Lasofoxifene In ESR1 Mutations Phase 2 Study At The 4th Annual Congress Of The ISLB NOTE: Sermonix Licensed Lasofoxifene Globally From Ligand Pharmaceuticals

By Benzinga Newsdesk

Today, 8:12 PM

Sermonix Pharmaceuticals Inc., a privately held biopharmaceutical company developing innovative therapeutics to specifically treat ESR1-mutated metastatic breast and gynecological cancers, today shared additional

LGND

4 minute read

Aligos Therapeutics To Present Nonclinical And Clinical Data For Its Chronic Hepatitis B And NASH Portfolio At AASLD’s The Liver Meeting 2022 November 4-8

By Benzinga Newsdesk

Today, 8:12 PM

Aligos Therapeutics, Inc. (NASDAQ:ALGS), a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in viral and liver diseases, today announced seven upcoming

ALGS

1 minute read

BrainStorm Cell Therapeutics Presents NurOwn Phase 2 Progressive MS Biomarker Data at the 38th ECTRIMS Congress

By Charles Gross

Today, 8:12 PM

BrainStorm Cell Therapeutics Inc.

BCLI

2 minute read

Events
News

AstraZeneca to Present New Data Across its Vaccines and Immune Therapies Portfolio at IDWeek

By Charles Gross

Today, 8:12 PM

AstraZeneca will showcase new data across its Vaccines and Immune Therapies portfolio at the 11th annual IDWeek conference, 19 - 23 October 2022, reinforcing its commitment to deliver long-lasting immunity for millions of people globally. The Company is set to present seven abstracts at the event.

AZN

2 minute read

NGOs Raise Money To Help Stem Opioid Addiction With Psychedelics Program

By Lara Goldstein

Today, 8:12 PM

The 100 Million Ways Foundation (100MW), a not-for-profit organization focused on harm reduction and improving quality of life of those with opioid use disorders, pulled in nearly $100,000 in fundraising at a recent gala commemorating the work carried out so far.

CCHWF

2 minute read

Will Colgate Spin Off Pet Food Biz? This Hedge Fund Hopes So, Plus 2 Dividend Stocks It Trades

By Robert Kuczmarski

Today, 8:12 PM

Activist investor Dan Loeb recently aired, and retracted, his statements on whether Walt Disney Co. (NYSE: DIS) should spin off ESPN.